157 related articles for article (PubMed ID: 9060701)
1. Expression of a murine leukemia virus Gag-Escherichia coli RNase HI fusion polyprotein significantly inhibits virus spread.
VanBrocklin M; Ferris AL; Hughes SH; Federspiel MJ
J Virol; 1997 Apr; 71(4):3312-8. PubMed ID: 9060701
[TBL] [Abstract][Full Text] [Related]
2. Capsid-targeted viral inactivation can eliminate the production of infectious murine leukemia virus in vitro.
VanBrocklin M; Federspiel MJ
Virology; 2000 Feb; 267(1):111-23. PubMed ID: 10648188
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of Gag-nuclease fusion protein on retrovirus-infected cell cultures.
Schumann G; Qin L; Rein A; Natsoulis G; Boeke JD
J Virol; 1996 Jul; 70(7):4329-37. PubMed ID: 8676455
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of a Gag-nuclease fusion protein against retroviral infection in vivo.
Schumann G; Hermankova M; Cannon K; Mankowski JL; Boeke JD
J Virol; 2001 Aug; 75(15):7030-41. PubMed ID: 11435583
[TBL] [Abstract][Full Text] [Related]
5. Mutations affecting the MA portion of the v-Abl protein reveal a conserved role of Gag in Abelson murine leukemia virus (MLV) and Moloney MLV.
Yi CR; Rosenberg N
J Virol; 2008 Jun; 82(11):5307-15. PubMed ID: 18367522
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the RNase H C helix of the Moloney murine leukemia virus reverse transcriptase reveal defects in polypurine tract recognition.
Lim D; Orlova M; Goff SP
J Virol; 2002 Aug; 76(16):8360-73. PubMed ID: 12134040
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the moloney murine leukemia virus RNase H domain.
Lim D; Gregorio GG; Bingman C; Martinez-Hackert E; Hendrickson WA; Goff SP
J Virol; 2006 Sep; 80(17):8379-89. PubMed ID: 16912289
[TBL] [Abstract][Full Text] [Related]
8. Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme.
Menéndez-Arias L; Gotte D; Oroszlan S
Virology; 1993 Oct; 196(2):557-63. PubMed ID: 8372434
[TBL] [Abstract][Full Text] [Related]
9. Identification of a cytoplasmic targeting/retention signal in a retroviral Gag polyprotein.
Choi G; Park S; Choi B; Hong S; Lee J; Hunter E; Rhee SS
J Virol; 1999 Jul; 73(7):5431-7. PubMed ID: 10364290
[TBL] [Abstract][Full Text] [Related]
10. Targeting of a nuclease to murine leukemia virus capsids inhibits viral multiplication.
Natsoulis G; Seshaiah P; Federspiel MJ; Rein A; Hughes SH; Boeke JD
Proc Natl Acad Sci U S A; 1995 Jan; 92(2):364-8. PubMed ID: 7831291
[TBL] [Abstract][Full Text] [Related]
11. An internal ribosomal entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors.
Berlioz C; Darlix JL
J Virol; 1995 Apr; 69(4):2214-22. PubMed ID: 7884868
[TBL] [Abstract][Full Text] [Related]
12. The nucleocapsid domain is responsible for the ability of spleen necrosis virus (SNV) Gag polyprotein to package both SNV and murine leukemia virus RNA.
Certo JL; Kabdulov TO; Paulson ML; Anderson JA; Hu WS
J Virol; 1999 Nov; 73(11):9170-7. PubMed ID: 10516024
[TBL] [Abstract][Full Text] [Related]
13. Transport and assembly of gag proteins into Moloney murine leukemia virus.
Hansen M; Jelinek L; Whiting S; Barklis E
J Virol; 1990 Nov; 64(11):5306-16. PubMed ID: 1698996
[TBL] [Abstract][Full Text] [Related]
14. Human APOBEC3G incorporation into murine leukemia virus particles.
Kremer M; Bittner A; Schnierle BS
Virology; 2005 Jun; 337(1):175-82. PubMed ID: 15914230
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus.
Ott DE; Coren LV; Copeland TD; Kane BP; Johnson DG; Sowder RC; Yoshinaka Y; Oroszlan S; Arthur LO; Henderson LE
J Virol; 1998 Apr; 72(4):2962-8. PubMed ID: 9525617
[TBL] [Abstract][Full Text] [Related]
16. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein.
Cimarelli A; Luban J
J Virol; 1999 Jul; 73(7):5388-401. PubMed ID: 10364286
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation Requirement of Murine Leukemia Virus p12.
Brzezinski JD; Felkner R; Modi A; Liu M; Roth MJ
J Virol; 2016 Dec; 90(24):11208-11219. PubMed ID: 27707931
[TBL] [Abstract][Full Text] [Related]
18. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.
Kondo E; Mammano F; Cohen EA; Göttlinger HG
J Virol; 1995 May; 69(5):2759-64. PubMed ID: 7707498
[TBL] [Abstract][Full Text] [Related]
19. Repression of the Chromatin-Tethering Domain of Murine Leukemia Virus p12.
Brzezinski JD; Modi A; Liu M; Roth MJ
J Virol; 2016 Dec; 90(24):11197-11207. PubMed ID: 27707926
[TBL] [Abstract][Full Text] [Related]
20. Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.
Lee SK; Nagashima K; Hu WS
J Virol; 2005 Apr; 79(7):4159-69. PubMed ID: 15767417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
